Clinical Trials Sponsored by ZOL

Total 322 results

ZOL

Not yet recruiting

Observational Comparison of Tooth-borne, Bone-borne and Hybrid Distraction Following SARPE. (SARPE)

Malocclusion
ZOL

Unknown

Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Corail Prosthesis With or Without Collar Design

Coxarthritis
ZOL

Completed

Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention

Coxarthritis

Belgium
Hasselt University
ZOL

Recruiting

Hyperventilation in Patients With Chronic Low Back Pain (HELBP)

Low Back Pain, Recurrent | Hyperventilation Syndrome

Belgium
PXL University College
Jessa Hospital; ZOL

Active, not recruiting

The Newborn Early Warning System (NEWS)

Development Tool NEWS

Belgium
Hasselt University
TRACE labs Ziekenhuis Oost-Limburg (ZOL)

Recruiting

Interoception in Patients With Medically Unexplained Symptoms

Burnout, Psychological | Fibromyalgia

Belgium
Hasselt University
TRACE labs Ziekenhuis Oost-Limburg (ZOL)

Recruiting

Proprioception and Interoception in Patients With Fibromyalgia

Fibromyalgia

Belgium
QOL Medical, LLC

Recruiting

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Congenital Sucrase-Isomaltase Deficiency | CSID | Sucrase Isomaltase Deficiency

United States
Associazione Qol-one

Completed

Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients

Acute Myeloid Leukemia

Italy
Zoll Medical Corporation

Completed

Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study (ASAP)

Syncope

United States
Zoll Medical Corporation

Enrolling by invitation

RapidShock Post-Approval Study

Cardiac Arrest

United States
Zoll Medical Corporation

Completed

Heart Failure Optimization Study (HF-Opt)

Heart Failure | Sudden Cardiac Death | Sudden Cardiac Arrest | Heart Failure Low Output

France, United States, Germany, Austria
Zoll Medical Corporation

Completed

Heart Sounds Registry (HEARIT-Reg)

Heart Failure; With Decompensation

United States, Austria, Germany, Poland
Zoll Medical Corporation

Completed

Measuring Thoracic Impedance in Hemodialysis Patients With the u-Cor Monitoring System (MaTcH)

Fluid Retention Tissue

United States
Associazione Qol-one

Terminated

Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q

Myelodysplastic Syndromes

France, Italy, Greece
Zoll Medical Corporation

Recruiting

Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction (COG01)

Heart Failure | Central Sleep Apnea

Poland
Associazione Qol-one

Recruiting

Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD (Phoenix)

Myelodysplastic Syndromes | Anemia | Transfusion-dependent Anemia | Del(5Q)

Italy
QOL Medical, LLC

Completed

Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance

Fructan Intolerance

United States
Zoe Global Limited

Active, not recruiting

ZOE's Ferment Experiment (ZHS-FE)

Mood | Hunger | Energy

United Kingdom
Zoll Medical Corporation

Active, not recruiting

Benefits of µCor in Ambulatory Decompensated Heart Failure (BMADHF)

Heart Failure

United States, Germany, Austria
Zoll Medical Corporation

Enrolling by invitation

Pre-hospital Ventilation Clinical Study

Heart Failure | Sepsis | Hemorrhage | Cardiac Arrest | Respiratory Distress Syndrome, Adult | Altered Mental Status

United States
QOL Medical, LLC

Completed

Adult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath Test

Congenital Sucrase-Isomaltase Deficiency

United States
Zoll Medical Corporation

Completed

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients (MAPS)

Cardiac Arrhythmia

United States
Zoll Medical Corporation

Completed

Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH) (PATCH)

Heart Arrhythmia

Germany
Zoll Medical Corporation

Terminated

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study (WED-HED)

Sudden Cardiac Death | Sudden Cardiac Arrest

United States
Zoll Medical Corporation

Completed

Intubation Assist Clinical Study

Intubation, Intratracheal

Norway
Zoll Medical Corporation

Terminated

LifeVest Post-CABG Registry

Myocardial Ischemia | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Sudden Cardiac Death

United States
Zoll Medical Corporation

Recruiting

Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator (OPT-BB WOMEN)

Heart Failure | Cardiomyopathies

United States
Zoll Medical Corporation

Recruiting

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator (ACAB)

Heart Failure

United States
Zoll Medical Corporation

Completed

Benefits of Microcor in Ambulatory Decompensated Heart Failure (BMAD-TX)

Heart Failure

United States, Germany, Austria, France
Zoll Medical Corporation

Withdrawn

Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation (MAPS-III)

Cardiac Event | Cardiac Disease | STEMI | Heart Attack | Cardiac Infarct | NSTEMI
Zoll Medical Corporation

Enrolling by invitation

Rapid Treatment of Shock Without Trauma (SWOT)

Shock

United States
Zoll Medical Corporation

Completed

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes (MAPS II)

Cardiac Arrhythmia

United States
Zoll Medical Corporation

Enrolling by invitation

AED 3 Post-Approval Study

Cardiac Arrest, Out-Of-Hospital

United States
Associazione Qol-one

Active, not recruiting

Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes | Thrombocytopenia

France, Germany, Italy, Slovenia
Zoll Medical Corporation

Completed

Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) Study

Heart Failure

United States
Zoll Medical Corporation

Completed

LifeVest Trends Validation Protocol (TRENDS)

Heart Failure

United States, Germany, Austria
Zoll Medical Corporation

Completed

LifeVest Safety and Efficacy in Real Life Settings in France (WEARIT France)

Sudden Cardiac Death | Cardiac Event | Cardiac Arrythmias | Left Ventricular Dysfunction

France
Zoll Medical Corporation

Completed

Verification of Prediction Algorithm (VPAC)

Bradycardia | Tachycardia | Difficulty Breathing | Shortness of Breath Episode

United States, Belgium
Zoll Medical Corporation

Completed

Study of the Wearable Defibrillator in Heart-Failure Patients (SWIFT)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Sudden Death | Sudden Cardiac Arrest

Israel, United States
QOL Medical, LLC

Withdrawn

A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency (GSID-E)

Genetic Sucrase-Isomaltase Deficiency
Zoll Medical Corporation

Completed

Hospital Wearable Defibrillator Inpatient Study (HWD)

In-Hospital Cardiac Arrest

United States
SAV-IOL SA
CEISO

Recruiting

Evaluation of Efficacy and Long-term Safety for Lucidis Instant Focus© - PMCF Study Protocol

Cataract

Switzerland
Liqun Zou

Recruiting

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Leukemia

China
ZOLL Circulation, Inc., USA

Active, not recruiting

REperfusion With Cooling in CerebraL Acute IscheMia II (RECCLAIM-II)

Ischemic Stroke

United States
Sol-Gel Technologies, Ltd.

Terminated

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Recurrent Basal Cell Carcinoma

United States
Sol-Gel Technologies, Ltd.

Completed

A Study of S6G5T3 in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Sol-Gel Technologies, Ltd.

Completed

Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

Actinic Keratosis (AK)

United States
Diaxonhit
Olivier SOL, MD

Completed

Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center (DIALOG)

Cognitive Impairment | Memory Complaint | Clinical Investigation in Memory Centers
Hospital Costa del Sol

Recruiting

Effectiveness of a Multifactorial Intervention in Frailty Individuals With HIV Infection: HIDRA360 (HIDRA360)

HIV Infections | Frailty Syndrome

Spain

Clinical Trials Sponsored by ZOL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations